Company profile
Brainomix Limited
AI-Powered Imaging Biomarkers for Better Treatment | Radiology AI
Brainomix has developed automated medical software for stroke image analysis, and lung diseases such as NSCLC and IPF. Our Radiology AI biomarkers enable precision medicine for better treatment.
Corporate ownership
Updated 06 Jun 2026 16:52
Company events
Reference milestones and recent Companies House filing stream events.
Accounts due
Accounts DueNext accounts due date
Confirmation statement due
Confirmation DueNext confirmation statement due date
Accounts With Accounts Type Group
Accounts Awaiting analysisAA | Transaction MzUxNDEzNjU4OWFkaXF6a2N4
Published 02 Apr 2026 15:33
Accounts filed
AccountsLast accounts made up date
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Accounts With Accounts Type Small
Accounts PDF pendingAA | Transaction MzQzNzY4NjAzNGFkaXF6a2N4 | Paper/PDF filed
Published 04 Oct 2024 11:22
Incorporated
InceptionCompany registered at Companies House
Public funding
Projects
Remote stroke diagnosis and treatment platform (RESDAT)
1 Jan 2024 to 30 Jun 2025
Rapid diagnosis and treatment of stroke is critical in improving outcomes for stroke, which is the leading cause of serious long-term disability globally. Stroke is the fourth largest cause of death in the UK and costs £25.6 billion annually. The most common type of stroke is a large vessel occlusion which is a clot lodged in a major artery in the brain. ...
National Consortium of Intelligent Medical Imaging (NCIMI)
1 Jan 2019 to 31 Mar 2023
"We have formed a consortium of collaborating hospitals and commercial companies with public and patient involvement and input from charities to enable us to work with the public and the NHS to best develop and test the use of Artificial Intelligence programmes to improve health care. We are working with university academics and NHS hospitals across the c...
Imaging software to quantify salvageable brain tissue to select stroke patients
1 Oct 2015 to 30 Sep 2017
Worldwide annually, 13,000,000 patients suffer a stroke. Mechanical clot removal (endovascular treatment) is expected to increase from 1% to 10% of patients, as recent studies show it improves patient outcome. It costs up to £23,000 per patient, making patient selection crucial for its adoption. Brainomix has developed the medical imaging software, e-ASPE...
Selection of ischemic stroke patients that would benefit from thrombolysis using an automated scoring system (e-ASPECTS) on computated tomography brain scans
1 Sep 2013 to 31 Mar 2015
Stroke is the third cause of death and the first cause of adult disability in the UK. Each year, there are about 110,000 strokes in the UK, 1 million in the European Union and 15 million worldwide. For the NHS, the direct and indirect costs amount to £9 billion. The majority of strokes (~90%) are ischaemic and caused by an occlusion of a brain artery. The...
Selection of ischemic stroke patients that would benefit from thrombolysis using an automated scoring system (e-ASPECTS) on computated tomography brain scans
1 Sep 2012 to 28 Feb 2013
Awaiting Public Project Summary